MedTrace Logo

Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)

NCT04252963 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2020-02-05

No results posted yet for this study

Summary

A phase 4 study to evaluate efficacy and safety of MUCOLASE tablet (streptokinase • streptodornase)

Conditions

  • Acute Upper Respiratory Infection
  • Acute Bronchitis

Interventions

DRUG

MUCOLASE tablet (streptokinase • streptodornase)

streptokinase • streptodornase 5mg

DRUG

Placebo

Placebo of MUCOLASE tablet

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Principal Investigators

  • Kwang-Ha Yoo, MD, Ph.D · Konkuk University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-02
Primary Completion
2021-02-28
Completion
2021-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04252963 on ClinicalTrials.gov